• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对肾细胞癌作为首发和第二原发癌的全面分析。

A comprehensive analysis of renal cell carcinoma as first and second primary cancers.

机构信息

Department of Urologic Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, No 1, East Banshan Road, Gongshu District, Hangzhou, 310022, People's Republic of China.

出版信息

World J Surg Oncol. 2022 Feb 27;20(1):57. doi: 10.1186/s12957-022-02493-6.

DOI:10.1186/s12957-022-02493-6
PMID:35220978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8883617/
Abstract

OBJECTIVE

Second primary renal cell carcinoma (2nd RCC) refers to renal cell carcinoma (RCC) diagnosed after another unrelated malignancy. This study aims to compare the clinical manifestation, pathology, treatment, and prognostic features of patients with 2nd RCC and first primary renal cell carcinoma (1st RCC).

MATERIALS AND METHODS

Data of the patients with localized RCC were retrospectively collected. They were classified as 2nd RCC or 1st RCC according to a previously diagnosed cancer, including 113 cases of 2nd RCC and 749 cases of 1st RCC.

RESULTS

The most common types of extrarenal malignancies in patients with 2nd RCC include lung, colorectal, breast, gynecological, and gastric cancers. The age and smoking rate of 2nd RCC patients were significantly higher than in those of 1st RCC patients. For 2nd RCC patients, fewer had clinical symptoms and renal masses tend to be smaller. One hundred and eight (95.6%) patients with 2nd RCC received surgical interventions. All patients with 1st RCC underwent renal surgery. More patients with 2nd RCC underwent a partial nephrectomy. Pathologically, there was no significant difference in postoperative pathological types between the 2nd and 1st RCCs. However, the 2nd RCCs were commonly identified in the early stages. The median overall survival (OS) of 2nd RCC patients was 117 months, which was shorter than that of 1st RCC patients.

CONCLUSIONS

Second RCC is not uncommon. More attention should be paid to screening for 2nd RCC in cancer survivors. There are some differences between patients with 2nd and 1st RCCs that should be viewed separately.

摘要

目的

第二原发肾细胞癌(2nd RCC)是指在另一种无关恶性肿瘤诊断后发生的肾细胞癌(RCC)。本研究旨在比较 2nd RCC 和首发性肾细胞癌(1st RCC)患者的临床表现、病理、治疗和预后特征。

材料和方法

回顾性收集局限性 RCC 患者的数据。根据既往诊断的癌症将其分为 2nd RCC 或 1st RCC,其中 2nd RCC 113 例,1st RCC 749 例。

结果

2nd RCC 患者最常见的肾外恶性肿瘤类型包括肺癌、结直肠癌、乳腺癌、妇科和胃癌。2nd RCC 患者的年龄和吸烟率明显高于 1st RCC 患者。2nd RCC 患者的临床症状较少,肾脏肿块较小。108 例(95.6%)2nd RCC 患者接受了手术干预。所有 1st RCC 患者均接受了肾切除术。更多的 2nd RCC 患者接受了部分肾切除术。术后病理类型在 2nd 和 1st RCC 之间无显著差异。然而,2nd RCC 通常在早期被发现。2nd RCC 患者的中位总生存期(OS)为 117 个月,短于 1st RCC 患者。

结论

2nd RCC 并不少见。癌症幸存者应更加注意筛查 2nd RCC。2nd 和 1st RCC 患者之间存在一些差异,应分别对待。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d335/8883617/29691154cfdc/12957_2022_2493_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d335/8883617/29691154cfdc/12957_2022_2493_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d335/8883617/29691154cfdc/12957_2022_2493_Fig1_HTML.jpg

相似文献

1
A comprehensive analysis of renal cell carcinoma as first and second primary cancers.对肾细胞癌作为首发和第二原发癌的全面分析。
World J Surg Oncol. 2022 Feb 27;20(1):57. doi: 10.1186/s12957-022-02493-6.
2
Evaluation of functional outcome of bilateral kidney tumors after sequential surgery.双侧肾肿瘤序贯手术后功能结局的评估。
BMC Cancer. 2021 May 24;21(1):592. doi: 10.1186/s12885-021-08324-3.
3
The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.原发肿瘤小与转移性肾细胞癌预后的关系:接受细胞减灭性肾切除术的患者的两个独立队列的研究结果。
Eur Urol Oncol. 2020 Feb;3(1):47-56. doi: 10.1016/j.euo.2019.10.002. Epub 2019 Nov 14.
4
The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.时间呈现方式对散发性双侧肾肿块患者临床和病理结局的影响。
Eur Urol. 2008 Oct;54(4):855-63. doi: 10.1016/j.eururo.2008.04.079. Epub 2008 May 9.
5
Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.终末期肾病患者自体肾中肾细胞癌(RCC)的临床和病理结果:一项与普通人群中诊断出的RCC进行的长期比较性回顾性研究。
World J Urol. 2015 Jan;33(1):1-7. doi: 10.1007/s00345-014-1248-y. Epub 2014 Feb 7.
6
Associations between presenting symptoms, clinicopathological parameters, and prognosis in a contemporary series of patients with renal cell carcinoma.当代肾癌患者系列中首发症状、临床病理参数与预后之间的关联。
Korean J Urol. 2014 Aug;55(8):505-10. doi: 10.4111/kju.2014.55.8.505. Epub 2014 Aug 8.
7
Pathologic and clinical characteristics of early onset renal cell carcinoma.早期发病的肾细胞癌的病理和临床特征。
Hum Pathol. 2018 Apr;74:25-31. doi: 10.1016/j.humpath.2017.11.005. Epub 2017 Nov 11.
8
Diagnosis and treatment of renal cell carcinoma in children: a report from the Polish pediatric rare tumor study group.儿童肾细胞癌的诊断与治疗:来自波兰儿科罕见肿瘤研究组的报告
Klin Padiatr. 2011 May;223(3):138-41. doi: 10.1055/s-0031-1275349. Epub 2011 Apr 20.
9
Prognostic significance of extensive necrosis in renal cell carcinoma.肾细胞癌广泛坏死的预后意义
Hum Pathol. 2017 Aug;66:108-114. doi: 10.1016/j.humpath.2017.06.010. Epub 2017 Jun 29.
10
Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.美国 T1bN0M0 期肾细胞癌(RCC)采用部分肾切除术和根治性肾切除术治疗后的生存:倾向评分法。
BJU Int. 2012 May;109(10):1457-62. doi: 10.1111/j.1464-410X.2011.10597.x. Epub 2011 Sep 20.

引用本文的文献

1
TET1 methylation and mRNA expression in renal cell carcinoma: implications for tumor staging and prognosis.肾细胞癌中TET1的甲基化和mRNA表达:对肿瘤分期及预后的意义
Eur J Med Res. 2025 Aug 20;30(1):778. doi: 10.1186/s40001-025-03051-y.
2
Clinical and survival differences between second primary and first primary nasopharyngeal carcinoma in a retrospective study.一项回顾性研究中第二原发性与第一原发性鼻咽癌的临床及生存差异
Discov Oncol. 2025 Aug 12;16(1):1538. doi: 10.1007/s12672-025-03250-3.
3
A Rare Case of Concurrent Chromophobe Renal Cell Cancer with Lung Neuroendocrine Tumor: A Case Report and Literature Review.

本文引用的文献

1
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
2
The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications.肥胖在肾细胞癌患者中的作用:临床病理意义。
Int J Mol Sci. 2019 Nov 13;20(22):5683. doi: 10.3390/ijms20225683.
3
Tobacco smoking after diagnosis of cancer: clinical aspects.癌症诊断后的吸烟情况:临床方面
一例肾嫌色细胞癌合并肺神经内分泌肿瘤的罕见病例:病例报告及文献复习
Ann Med Surg (Lond). 2024 Feb 19;86(4):2230-2235. doi: 10.1097/MS9.0000000000001841. eCollection 2024 Apr.
4
Altered NCR3 Splice Variants May Result in Deficient NK Cell Function in Renal Cell Carcinoma Patients.改变的 NCR3 剪接变异可能导致肾细胞癌患者的 NK 细胞功能缺陷。
In Vivo. 2024 Jan-Feb;38(1):174-183. doi: 10.21873/invivo.13423.
Transl Lung Cancer Res. 2019 May;8(Suppl 1):S50-S58. doi: 10.21037/tlcr.2019.04.01.
4
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.欧洲泌尿外科学会肾癌指南:2019 年更新版。
Eur Urol. 2019 May;75(5):799-810. doi: 10.1016/j.eururo.2019.02.011. Epub 2019 Feb 23.
5
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.肾细胞癌:ESMO 诊断、治疗及随访临床实践指南†
Ann Oncol. 2019 May 1;30(5):706-720. doi: 10.1093/annonc/mdz056.
6
Obesity and cancer risk: Emerging biological mechanisms and perspectives.肥胖与癌症风险:新兴的生物学机制与展望。
Metabolism. 2019 Mar;92:121-135. doi: 10.1016/j.metabol.2018.11.001. Epub 2018 Nov 13.
7
Impact of smoking on multiple primary cancers survival: a retrospective analysis.吸烟对多原发癌生存的影响:一项回顾性分析。
Clin Exp Med. 2018 Aug;18(3):391-397. doi: 10.1007/s10238-018-0498-1. Epub 2018 Mar 17.
8
Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study.2012 年全球 20-39 岁年轻人癌症发病率和死亡率:一项基于人群的研究。
Lancet Oncol. 2017 Dec;18(12):1579-1589. doi: 10.1016/S1470-2045(17)30677-0. Epub 2017 Oct 27.
9
Clinical characteristics of second primary pancreatic cancer.第二原发性胰腺癌的临床特征
PLoS One. 2017 Jun 26;12(6):e0179784. doi: 10.1371/journal.pone.0179784. eCollection 2017.
10
Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.继发原发性肾癌风险:一项基于人群的研究。
Clin Genitourin Cancer. 2017 Oct;15(5):e747-e754. doi: 10.1016/j.clgc.2017.02.004. Epub 2017 Feb 27.